Concepedia

Hashmi Rafeek

HR

Statistics

Publications

5

Citations

207

H-Index

5

Active since

2012

Affiliations

University of Pennsylvania(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Columbia University

Hashmi Rafeek is an author at University of Pennsylvania specializing in lipid-lowering therapy, pharmacotherapy, and pharmacology.

Publications per year

2012–2017

5

Publications

5

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects

John S. Millar, Gissette Reyes‐Soffer, Patricia Jumes et al. · Journal of Clinical Investigation · 2015 · 88 citations · Full text

, , +16

Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein

Gissette Reyes‐Soffer, John S. Millar, Colleen Ngai et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2016 · 40 citations · Full text

, , +14

Ascending and descending thoracic aorta calcification in type 2 diabetes mellitus

Timothy W. Churchill, Suraj P. Rasania, Hashmi Rafeek et al. · Journal of cardiovascular computed tomography · 2015 · 34 citations

, , +14

Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E

John S. Millar, Michael E. Lassman, Tiffany Thomas et al. · Journal of Lipid Research · 2017 · 23 citations · Full text

, , +17

Cardiovascular risk factors and mitral annular calcification in type 2 diabetes

Atif Qasim, Hashmi Rafeek, Suraj P. Rasania et al. · Atherosclerosis · 2012 · 22 citations

, , +13

1–5 of 5